Orexigen Bankruptcy Shows Difficulty of Marketing Weight-Loss Drugs

Drugmaker Orexigen filed for bankruptcy protection on Monday and plans to sell itself, after failing to find a profitable market for its weight-loss treatment Contrave.

from WSJ.com: US Business http://ift.tt/2DlF1zv
via IFTTT